WebApr 7, 2024 · GILD opened at $83.37 on Friday. Gilead Sciences, Inc. has a fifty-two week low of $57.17 and a fifty-two week high of $89.74. The business has a 50-day moving average of $82.11 and a 200-day moving average of $79.98. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.29 and a quick ratio of 1.15. WebApr 11, 2024 · 17 Wall Street analysts have issued 1-year target prices for Gilead Sciences' stock. Their GILD share price forecasts range from $70.00 to $112.00. On average, they anticipate the company's stock price to reach $89.40 in the next year. This suggests a possible upside of 7.2% from the stock's current price. View analysts price targets for …
Gilead Sciences - GILD Stock Forecast, Price & News - MarketBeat
WebApr 14, 2024 · The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.16% of the stock is owned by insiders. Gilead Sciences Profile . Gilead Sciences, Inc is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. WebFind the latest SEC Filings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. markhams king williams town
Exhibit - SEC
WebDec 31, 2024 · Gilead Sciences, Inc. (“Gilead,” “we,” “our” or “us”) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three … WebApr 9, 2024 · Exchange Traded Concepts LLC trimmed its position in Gilead Sciences, Inc. ( NASDAQ:GILD - Get Rating) by 29.9% during the 4th quarter, according to its most … WebDetailed Profile of GILEAD CAPITAL LP portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more. ... Gilead Capital is a hedge fund with 17 clients and discretionary assets under management (AUM) of $105,951,882 (Form ADV from 2024-09-13). Whalewisdom has at least 9 13D filings, and 2 13G filings navy base in memphis